Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

17:46
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12-0 in favour of the demonstrated benefit of monotherapy treatment with belantamab mafodotin outweighing...

14:00
Published online on June 15, 2020 in The International Journal of Listening, the article titled Changes in Auditory Processing After Completing The Listening Program Training is authored by Tracey Butler, Jane Schueler, and Jay R. Lucker, Professor...

10:00
The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19....

09:33
VeraSci, a leading provider of innovative scientific and technology services, announced today the expansion of their proprietary eCOA platform to fully integrate the Neurostatus-EDSS assessment and Neurostatus data clarification services for MS...

08:17
Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced results from...

08:14
The CorNeat KPro, the first synthetic cornea that bio-integrates with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The clinical trial, approved by Israel's Ministry of Health, will include 10 corneally...

08:00
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) announces that its subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. ("Fosun Pharmaceutical Industrial") has received the...

08:00
Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today announced the initiation of an investigator-sponsored study evaluating the use of vadadustat, Akebia's...

07:30
Mydecine Innovations Group Inc. ("Mydecine" or the "Company"), is pleased to announce that, further to its press release on June 10, 2020, it has entered into a definitive share exchange agreement (the "Share Exchange Agreement") for the...

07:30
Rigel Pharmaceuticals, Inc.  today announced the initiation of an investigator-sponsored trial (IST) being conducted by Imperial College London to evaluate the efficacy of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the...

07:00
Sanofi and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune-therapies, for patients with cancer. The...

06:00
VolitionRx Limited ("Volition"), a multi-national epigenetics company applying its Nu.Qtm Nucleosomicstm technology to develop simple, cost effective blood-based tests for cancer and other diseases, today announced that results from two proof of...

02:13
BioArctic AB (publ) announced today that its business partner Eisai, in collaboration with Alzheimer's Clinical Trials Consortium (ACTC) and Biogen, has initiated a new global Phase 3 clinical study (AHEAD 3-45) with BAN2401, an anti-amyloid beta...

01:00
EXACT THERAPEUTICS AS ("EXACT-Tx" or the "Company") (Oslo: EXTX-ME), a clinical stage precision medicine company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces that its shares have been admitted to...


13 july 2020

19:31
The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), and Biogen Inc. announced today that a new Phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (A?) protofibril...

16:30
Vanda Pharmaceuticals Inc. (Vanda) announced today that the U.S. Food and Drug Administration (FDA) has authorized a single patient in an Individual Patient Expanded Access protocol (VP-VLY-686-3303).  This patient had previously participated in a...

14:03
Merck, a leading science and technology company, today announced the winner of the Future Insight Prize 2020, worth ? 1 million. This year's topic "Multi-Drug...

11:00
Breast Cancer patients are 60 percent more likely to die of cancer after surviving a heart attack, a new study finds. Led by...

10:00
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, is establishing a general grant program to support the education of African-American patients about cutaneous T-cell...

09:35
Therapeutics Solution International, Inc., , reported today new data showing that the ingredients of QuadraMunetm suppress expression of an inflammation stimulated molecule which is known to induce coagulation of blood.  Inhibition of this...

09:00
INSIGHTEC, a global medical technology innovator of incisionless surgery, announced today achievement of complete Medicare coverage across all 50 states for MR-guided focused ultrasound treatment of medication-refractory Essential Tremor. "INSIGHTEC...

08:51
ExeGi Pharma LLC, a U.S.-based company focused on developing and commercializing products targeting the human microbiome, including live biotherapeutic products (LBPs), announced today the results of a 70-patient clinical trial evaluating a new...

08:00
BIOLASE, Inc. , the global leader in dental lasers, today announced data published in the Journal of Periodontology from a clinical trial conducted at The McGuire Institutetm. Designed to meet the stringent American Association of Periodontology Best...

08:00
Enzychem Lifesciences (KOSDAQ: 183490) today announced that it has filed an Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) for a Phase 2 clinical trial of EC-18 as a preventative therapeutic against Acute...

07:29
Cellular Biomedicine Group, Inc. ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, provided an overview and update of clinical and...

03:00
SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the...

02:40
Final results from the PUPs A-LONG and PUPs B-LONG studies assessing the efficacy and safety of Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa) in previously untreated patients (PUPs) with haemophilia A and B respectively were presented...


11 july 2020

03:00
MedAlliance has announced enrollment of the first patient in its study of SELUTION SLRtm 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Program'. The SELUTION SLR (Sustained...


10 july 2020

16:00
Kodiak Sciences Inc. , a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases today announced promising additional safety, efficacy and durability data from the ongoing Phase...

08:33
Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug ? CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial...

08:01
The Centre for Cell Manufacturing Ireland (CCMI) at the National University of Ireland Galway (NUI Galway) and Sexton Biotechnologies today announced the approval by an EU Regulatory Authority of a protocol for the manufacture of allogeneic bone...

08:00
MedAlliance has announced enrollment of the first patient in its study of SELUTION SLRtm 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Program'. The SELUTION SLR (Sustained...

01:19
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is...


9 july 2020

21:01
The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least...

16:30
VetCell Therapeutics USAtm, a clinical-stage, pet-focused cell therapy division of PrimeGen US Inc., announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) to begin a multi-centered, country-wide clinical...

13:31
AIkido Pharma Inc. ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic. As previously announced, on April 13, 2020, AIkido executed a Master License Agreement with the...

13:00
Journal of Oral Implantology ? After tooth loss due to disease, injury or other factors, dental implants improve quality of life. Maxillary sinus augmentation, a surgical procedure that grafts bone into the upper jaw, is often advised to create new...

12:00
Yokogawa Fluid Imaging Technologies, of Scarborough Maine announced today the release of its newest FlowCam with a fully integrated light obscuration module. By combining industry-standard light obscuration technology required for USP compliance with...

10:59
RaySearch Laboratories AB (publ) announces that its advanced deep learning segmentation functionality for lung delineation in breast radiation therapy has been carried out using treatment planning system RayStation® * at Leeds Cancer Centre (LCC) in...

09:35
A new clinical trial conducted by the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG) is the first in the world to test an immune-stimulating treatment to reduce symptoms and prevent severe cases of COVID-19 and other serious...

09:12
Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease....

09:00
Ardigen and CVC announced that they entered a research collaboration aimed at the development of SARS-CoV-2 vaccine. Ardigen's...

08:56
Endometriosis is a disease that can seriously compromise ovarian function and can therefore pose a threat to the fertility of women who suffer from it. In fact, approximately 50% of patients with endometriosis will experience infertility; therefore,...

08:33
COVID-19 patients have begun enrolling in an interventional clinical trial at Hospital Virgen del Carmen in Zarate, Argentina. The study will evaluate the therapeutic effect of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with...

08:15
Creative Medical Technology Holdings announced today completion of preclinical studies assessing the anti-inflammatory and neuroregenerative activities of AmnioStemtm. These studies complete what the Company believes is necessary for filing an...

08:00
HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has achieved a research milestone in its collaboration with Horizon Therapeutics plc to discover and develop novel therapeutics for gout. In fewer than 18 months,...

06:00
IDEAYA Biosciences, Inc. , an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in the Phase 1 combination study of IDE196 and binimetinib, a MEK...

03:33
IRLAB announced today that a scientific paper reporting the distinctive pharmacological profile of IRL752, in development for the treatment of impaired balance and falls in Parkinson's disease, is accepted and published online in the Journal of...

03:00
Menarini Ricerche, the R&D division of the Menarini Group, announces that it has published four abstracts presenting the latest findings related to its meropenem/vaborbactam (Vaboremtm) and delafloxacin (Quofenixtm) clinical studies, confirming...

03:00
CEBINA GmbH, an Austrian biotech company, announces positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays. One of these drugs,...

1 2 3 4 5 6 7 8 9 10